
    
      A Phase I, Single Centre, Double-Blind, Randomised, Placebo- controlled, Parallel-group Study
      to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple
      Ascending Inhaled Doses of AZD8683 in Healthy Volunteers and COPD patients
    
  